semaglutide coming off shortage list FDA Ends Listing, Contributing to Ongoing Legal Challenges Hims & Hers can't sell

BPC-157 (Body Protection Compound): Research Applications: Wound healing (muscle, tendon, ligament, gut), anti-inflammatory effects, organ protection

Department of Health and Human Services, said in a statement

This genetic insight helps your provider understand whether your body responds optimally to standard semaglutide dosing or whether a different compoundlike tirzepatideor a dual-compound approach might align better with your peptide metabolism

One in five (18%) adults now report having ever taken a GLP-1 agonist, including 12% who say they are currently taking this type of medication (a 6 percentage point increase from 18 months ago)